Pharmaceutical

Articles

A Glance at Key Insights From 42nd J.P. Morgan Annual Healthcare Conclave

Explore More...
cancer-biomarkers-for-cancer-treatment

Cancer Biomarkers: Improving Treatment and Detection

Burn Ointment Market Trends, Developments, and Key Companies

Navigating the Key Trends and Major Advances in the Burn Ointment Market

Pharma News and Updates for Incyte, Eisai, Biogen, Reata Pharmaceuticals, Genenta Science, Harbour BioMed, Ikena Oncology

Incyte’s Clinical Trial for Myelofibrosis; Eisai and Bioge’s Leqembi; FDA Approves Reata Pharmaceuticals’ SKYCLARYS; Temferon Lands FDA Orphan Drug Status for Glioblastoma; Harbour BioMed Announces Results from Phase III Trial of Batoclimab; FDA Fast Track Designation to Ikena’s AHR Antagonist IK-175

acute-ischemic-stroke-treatment-outlook

Wider Administration Window – Need of the Moment for Acute Ischemic Stroke Patients

besremi-jakafi-rusfertide-for-polycythemia-vera-treatment

Polycythemia Vera Treatment: Besremi, Jakafi, and Rusfertide Analysis

Pharma News and Updates for SpringWorks Therapeutics, AskBio, Mitsubishi Tanabe Pharma America, Sage Therapeutics, Biohaven Pharma

SpringWorks’s Desmoid Tumors Therapeutic, Nirogacestat; Orphan Drug Designation to AskBio’s AB-1003; Mitsubishi Tanabe’s Phase 3 Trial of RADICAVA ORS in ALS; EU Orphan Drug Designation to Sage Therapeutics’s SAGE-718; FDA Fast Track Status to Biohaven’s Taldefgrobep Alfa

minimal-residue-disease-mrd-testing-market

Minimal Residual Disease (MRD) Testing: A Path to Cure Cancer?

ASCO GU 2023, Prostate & Urothelial Cancer Abstracts Highlights

A Quick Recap from ASCO GU 2023: Prostate and Urothelial Cancer Highlights

top-10-oncology-drugs-launches-2023

Top 10 Expected Oncology Drug Launches in 2023

Protein Supplements Market, Growing Demand, and Key Companies

How is Protein Supplements Market Evolving with the Ongoing Development?

donanemab-for-alzheimers-disease-treatment

The Road Ahead for Donanemab: Will the Therapy be the Next Imminent Breakthrough in the Alzheimer’s Disease Treatment Landscape?

epstein-barr-virus-ebv-treatment-outlook

Changing Landscape of EBV-associated Diseases Treatment: Is T-cell Immunotherapy the Answer?

ppar-and-nox-agonist-for-primary-biliary-cholangitis-treatment

PPAR and NOX Agonist: Savior of Underserved Primary Biliary Cholangitis Patients

Biologics in the Nasal Polyposis Treatment Market

Biologics Spark Market Interest In The Nasal Polyposis Treatment Space

Pharma News Updates for Merck, Sanofi, GSK, Hinova, Endogena, Amylyx

Merck’s Keytruda Wins Another FDA Approval; Sanofi Pauses Trial of Myasthenia Gravis Drug, tolebrutinib; FDA Approves GlaxoSmithKline’s Jesduvroq; FDA IND Application Clearance for Hinova’s HP518; FDA Fast Track Designation to Endogena’s EA-2353; Amylyx Updates on Global Phase 3 PHOENIX Trial

mercks-gefapixant-for-crc-treatment

Will Merck’s P2X3 Receptor Antagonist for Chronic Refractory Cough Treatment Be Able to Turn FDA’s Nay Into Yea?

Subscribe to our Updates

DelveInsight is dedicated to safeguarding your data. We ensure that your information is handled in compliance with relevant data privacy legislation, our internal guidelines, and our privacy policy.

Receive recent Healthcare updates directly in your inbox.

Days
loader